5-Bromopentan-1-ol | CAS:34626-51-2

We serve 5-Bromopentan-1-ol CAS:34626-51-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
5-Bromopentan-1-ol

Chemical Name:5-Bromopentan-1-ol
CAS.NO:34626-51-2
Synonyms:5-Bromopentan-1-ol
5-bromo-pentanol
5-bromopentane-1-ol
1-Pentanol,5-bromo
5-bromo-pentan-1-ol
5-bromopentyl alcohol
Molecular Formula:C5H11BrO
Molecular Weight:167.04400
 
Physical and Chemical Properties:
Density:1.38
Boiling point:117ºC
Flash point:93.3ºC
Index of Refraction:1.482
 
Specification:
Appearance:Yellow to dark yellow transparent liquid
Assay:≥95.0%
Moisture:≤0.3%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate



Contact us for information like 5-Bromopentan-1-ol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-bromopentyl alcohol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-bromopentyl alcohol Use and application,5-bromopentyl alcohol technical grade,usp/ep/jp grade.


Related News: Different cell types can be affected, although the most common finding in MDS is a shortage of red blood cells (anaemia). Patients with higher-risk MDS may progress to the development of acute leukaemia.N,N-dimethylformamide manufacturer Different cell types can be affected, although the most common finding in MDS is a shortage of red blood cells (anaemia). Patients with higher-risk MDS may progress to the development of acute leukaemia.(R)-5-Bromo-3-[(1-methyl-2-pyrrolidinyl)methyl]-1H-indole supplier Different cell types can be affected, although the most common finding in MDS is a shortage of red blood cells (anaemia). Patients with higher-risk MDS may progress to the development of acute leukaemia.Trimethoxy(propyl)silane vendor Different cell types can be affected, although the most common finding in MDS is a shortage of red blood cells (anaemia). Patients with higher-risk MDS may progress to the development of acute leukaemia.Different cell types can be affected, although the most common finding in MDS is a shortage of red blood cells (anaemia). Patients with higher-risk MDS may progress to the development of acute leukaemia.